ECOLAB INC. (ECL)
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Open ECOLAB INC. in the interactive graph- Ticker
- ECL
- SEC CIK
- 0000031462
- Sector
- Materials
- Industry
- Chemicals
- Periods
- FY2025, FY2025 Q1, FY2025 Q2, FY2026, FY2026 Q1, FY2026 Q2, FY2026 Q3, FY2027
- Headquarters
- Saint Paul, MN
- Employees
- 48,000
Key figures
- Revenue 4.07B USD
- NetIncome 432.60M USD
- DilutedEPS 1.70 USD/share
Reported figures
- BasicEPS 1.53 USD/share
- CapitalExpenditure 348.50M USD
- CashAndEquivalents 1.16B USD
- CashAndEquivalents 519.80M USD
- CostOfRevenue 2.06B USD
- CostOfRevenue 2.30B USD
- DilutedEPS 1.41 USD/share
- DilutedEPS 1.50 USD/share
- DilutedEPS 1.52 USD/share
- DilutedEPS 1.70 USD/share
- DilutedEPS 1.89 USD/share
- DilutedEPS 7.53 USD/share
- FreeCashFlow 97.40M USD
- GrossMargin 43.6 percent
- GrossMargin 43.8 percent
- GrossMargin 44.2 percent
- GrossMargin 44.4 percent
- GrossProfit 1.63B USD
- GrossProfit 1.77B USD
- InterestExpense 58.30M USD
- InterestExpense 72.70M USD
- NetIncome 402.50M USD
- NetIncome 427.10M USD
- NetIncome 432.60M USD
- NetIncome 482.50M USD
- OperatingIncome 26.60M USD
- OperatingIncome 264.10M USD
- OperatingIncome 299.30M USD
- OperatingIncome 301.20M USD
- OperatingIncome 348.20M USD
- OperatingIncome 37.70M USD
- OperatingIncome 46.50M USD
- OperatingIncome 51.90M USD
- OperatingIncome 555.30M USD
- OperatingIncome 589.60M USD
- OperatingIncome 622.00M USD
- OperatingIncome 679.70M USD
- OperatingMargin 14.6 percent
- OperatingMargin 14.7 percent
- OperatingMargin 15.3 percent
- and 21 more in the interactive graph
Guidance
- DilutedEPS guidance 2.02–2.12 USD/share
- DilutedEPS guidance 8.43–8.63 USD/share
- OperatingMargin guidance 19 percent
Drivers
- Accelerated volume growth contributed to strong performance
- Bioprocessing more than doubled its sales driving Life Sciences growth
- Currency translation increased earnings per share by $0.08
- Ecolab Digital and Global High-Tech both grew more than 20%, reflecting strong customer de
- Food & Beverage continued mid-single digit growth driven by attractive new business wins f
- Food & Beverage continued to significantly outperform market trends
- Headwind from softer sales in Heavy Water and Paper stabilized, driven by good new busines
- Heavy Water and Paper together reduced organic sales growth by low-single digits and organ
- Higher commodity costs offset by sales growth and improved productivity in Global Water
- Improved productivity supported operating income margin expansion
- Institutional and Specialty both improved performance
- Institutional's improved performance driven by good growth with hospitality customers
- Life Sciences accelerated to 11% growth, driven by bioprocessing which more than doubled i
- Lower cash balances and new debt used to fund Ovivo Electronics acquisition reduced adjust
- More than 20% organic growth in Global High-Tech reflecting robust growth across microelec
- Ovivo Electronics acquisition contributed 5% benefit to Global Water sales
- Pest Elimination grew 7% with strong gains from One Ecolab growth initiative and new pest
- Record new business wins expected to help offset rising commodity costs
- Robust growth in pharmaceutical & personal care contributed to Life Sciences performance
- Specialty's sales grew high-single digits with accelerated growth driven by robust new bus
- Strong organic sales growth in Pest Elimination led by robust gains in restaurants, food r
- Strong sales growth and improved productivity in Pest Elimination more than offset growth-
- Strong sales growth and lower supply chain costs in Life Sciences more than offset unfavor
- Strong sales growth in Global Institutional & Specialty more than offset higher commodity
- Strong value pricing drove accelerated sales growth and double-digit earnings growth
- Targeted acquisitions in North America contributed 1% benefit to Pest Elimination sales
- Temporary capacity constraints within Life Sciences' industrial water purification busines
Risks
- Commodity costs expected to increase high-single digits starting in the second quarter and
- Emerging challenges in the Middle East
- Global operating environment remains unpredictable, including constantly evolving geopolit
- Sharply rising global energy costs driven by geopolitical developments
- Short transition period expected in second quarter as benefits from energy surcharge progr
Corporate events
- Ecolab repurchased approximately 1.3 million shares of its common stock during the first q
- One Ecolab restructuring initiative ongoing with special charges of $31.4 million in first
- Ovivo Electronics acquisition completed in fourth quarter of 2025, contributing to Global
- Pending acquisition of CoolIT Systems expected to close during the third quarter of 2026,
Quotes
- “Accelerated organic sales growth this quarter was led by our growth engines, whi…”
- “As we move into the second quarter, we expect a short transition period as we ab…”
- “During the quarter, we responded quickly to sharply rising global energy costs d…”
- “The pending acquisition of CoolIT is an important strategic step for Ecolab, fur…”
- “We delivered another strong quarter, with accelerated sales growth and double-di…”